About
Ocular Drug Delivery Technology
Areas of Focus
Categories
Small Molecule PharmaceuticalDrug Delivery & FormulationSoutheastern U.S.
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
15
As Collaborator
0
Total Enrollment
1,318
By Phase
PHASE2: 4PHASE1/PHASE2: 3NA: 1PHASE3: 4
By Status
COMPLETED: 13TERMINATED: 2
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05891548Lead Sponsor
Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
PHASE2Completed
60 participants
Started: May 31, 2023 · Completed: Aug 20, 2024
NCT05131646Lead Sponsor
Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study
N/ACompleted
15 participants
Started: Oct 8, 2021 · Completed: Jan 5, 2023
NCT04626128Lead Sponsor
Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD
PHASE1/PHASE2Completed
27 participants
Started: Dec 15, 2020 · Completed: Oct 13, 2022
NCT04839770Lead Sponsor
MIECH: The Minimally Invasive Endoscopic Surgery With the Axonpen System for Spontaneous Intracerebral Hemorrhage
NACompleted
10 participants
Started: Aug 7, 2020 · Completed: Jan 31, 2023
NCT03203447Lead Sponsor
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
PHASE3Terminated
325 participants
Started: Mar 5, 2018 · Completed: Dec 18, 2018
Locations (1)
Headquarters
Alpharetta, GA, United States
Map
Loading map...